Mach7 Technologies Limited TDMMF
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About TDMMF
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Mach7 Technologies Limited is a medical imaging technology company focused on enterprise imaging solutions for healthcare providers. The company develops software platforms that enable the storage, management, viewing, sharing, and workflow orchestration of diagnostic medical images and associated patient data. Mach7 primarily operates within the healthcare information technology and medical imaging industries, serving hospitals, integrated delivery networks, radiology groups, and academic medical centers. Its core offerings are centered on vendor-neutral archive (VNA) technology, enterprise image management, diagnostic viewing, and interoperability solutions designed to integrate imaging data across disparate clinical systems.
The company’s primary revenue drivers include software licensing, subscription-based software-as-a-service arrangements, maintenance and support contracts, and professional implementation services. Mach7 has positioned itself as an interoperability-focused imaging platform provider capable of integrating with electronic medical records, PACS systems, and healthcare data environments from multiple vendors. Originally founded in Australia, the company evolved from imaging workflow and data management technologies into a broader enterprise imaging platform provider, expanding its footprint particularly in North America through product development, acquisitions, and partnerships with healthcare technology vendors.
Business Operations
Mach7 conducts operations through enterprise imaging software and related healthcare IT services. Its principal business units include the Enterprise Imaging Platform, Vendor Neutral Archive (VNA) solutions, and diagnostic image viewing technologies. The company generates revenue through software subscriptions, perpetual and term licensing agreements, recurring maintenance contracts, cloud-enabled deployments, and implementation services. A substantial portion of the company’s customer base is concentrated in healthcare systems seeking modernization of imaging infrastructure and interoperability across radiology, cardiology, pathology, and other imaging-intensive specialties.
The company maintains operations across both domestic Australian and international markets, with significant commercial activity in the United States, which has historically represented its largest revenue contributor. Mach7 controls proprietary imaging workflow and interoperability technologies designed to support scalable image access and data consolidation across healthcare environments. The company has also maintained strategic relationships with healthcare technology integrators and imaging ecosystem partners to support deployment and interoperability initiatives. Public disclosures identify Mach7 Technologies Inc. and related regional operating entities as part of the company’s operational structure supporting sales, implementation, and customer service functions.
Strategic Position & Investments
Mach7’s strategic direction has focused on expanding recurring software revenue, increasing cloud-enabled enterprise imaging deployments, and strengthening interoperability capabilities within healthcare systems. The company has emphasized growth in large-scale hospital networks and enterprise healthcare customers seeking alternatives to legacy imaging infrastructure. Strategic initiatives have included enhancing data migration capabilities, expanding image exchange functionality, and improving integration with electronic health record systems and artificial intelligence-enabled imaging workflows.
The company has also pursued acquisitions and technology integrations to broaden its enterprise imaging capabilities. Notably, the acquisition of Client Outlook Inc. expanded Mach7’s diagnostic viewing and clinical imaging workflow portfolio through the addition of the eUnity enterprise viewer platform. Mach7 has increasingly positioned itself within emerging healthcare digitization trends, including cloud imaging environments, enterprise interoperability, and data accessibility across multi-site healthcare systems. Publicly available filings and investor materials indicate continued investment in software innovation and North American market expansion as central components of corporate strategy.
Geographic Footprint
Mach7 Technologies Limited is headquartered in Melbourne, Australia, while maintaining a substantial operational and commercial presence in the United States. The company serves healthcare organizations across North America, Asia-Pacific, and selected international markets through direct sales efforts, channel relationships, and regional subsidiaries. The U.S. market has represented the company’s primary commercial focus due to the scale of healthcare imaging modernization initiatives among hospital systems and integrated care networks.
The company’s operational footprint includes customer deployments in multiple healthcare regions globally, with particular concentration in enterprise imaging projects across the United States and Canada. Mach7’s technologies are designed for large-scale healthcare environments requiring cross-border interoperability, centralized image management, and multi-site imaging access. Its international influence is primarily tied to software deployment and healthcare IT integration rather than physical infrastructure ownership.
Leadership & Governance
Mach7 Technologies Limited operates under a corporate governance structure overseen by its board of directors and executive leadership team. The company’s leadership strategy has emphasized enterprise imaging innovation, recurring revenue growth, customer retention, and expansion within large healthcare networks. Public company disclosures indicate a focus on scalable software delivery, operational discipline, and strategic healthcare IT partnerships.
Key executives and leadership figures include:
- Mike Lampron – Chief Executive Officer
- David Chambers – Chief Financial Officer
- Ravi Krishnan – Founder and Non-Executive Director
- John Moore – Chairman
- Brian Malcolm – Chief Operating Officer
The leadership team has consistently communicated a strategy centered on interoperability, cloud-oriented enterprise imaging solutions, and long-term penetration of large healthcare systems, particularly within the North American healthcare market.